V enous thromboembolism (VTE) is a severe medical health problem that affects ≈1 per 1000 individuals each year. [1] [2] [3] Familial thrombophilia, ie, clustering of VTE, was recognized at the beginning of the 19th century. 4 Like many common human diseases and traits that cluster in families, VTE is considered a complex disorder influenced by several genetic and environmental factors. 5 Inherited deficiencies of the natural anticoagulant inhibitors antithrombin, protein C and proteins S, as well as activated protein C resistance because of the factor V Leiden variant (rs6025) and the prothrombin 20210A variant (rs1799963), have been associated with familial thrombophilia. 5 After the discovery of activated protein C resistance by Dahlbäck et al, 6 research has focused on the genetic contribution to VTE. However, the predictive value of family history for detecting any of the 5 major genetic risk factors is low, [7] [8] [9] [10] [11] [12] suggesting that other genetic or possibly nongenetic familial factors may be important.
Clinical Perspective on p 303
As is the case for many complex diseases, 13 the average familial risk of VTE in first-degree relatives is ≈2. 12, [14] [15] [16] [17] [18] [19] Although a familial risk of 2 might seem modest, it does suggest that uncovering genetic and nongenetic sources of familial aggregation might be worthwhile. 13 However, if familial environmental effects are strong, this might not be the case. Moreover, risks of the dissected underlying familial risk factors (genetic or nongenetic) are likely to be larger than the familial risk itself. 13 The 5 major identified genetic risk factors for VTE together account for only ≈30% of the family history. 12 Newly identified common, but much weaker, alleles probably only contribute to a small fraction of the familial risk for VTE. [20] [21] [22] [23] [24] [25] [26] It has been estimated that 10 additive alleles, each with a genotype relative risk of 2.0 and an allele frequency of 0.1, will only explain a familial risk of 1.06. 27 If multiplicative gene-gene interactions are present, the same 10 alleles will still only explain a familial risk of 1.2. 27 Most newly identified alleles have an estimated genotype relative risk <1.5. [20] [21] [22] [23] [24] [25] [26] An additive allele with an allele frequency of 0.1 and a genotype risk of 1.5 will only explain a familial risk of 1.01. 27 Thus, as for many other complex disorders, the source of the missing heritability of VTE remains to be determined. 28 The missing heritability of VTE might be genetic, epigenetic, nongenetic (because of familial environmental effects), or because of gene-gene interactions. 28 It is, however, difficult to disentangle the contributions of genetic and family environmental factors in family studies of VTE because most children, including dizygotic and monozygotic twins, grow up in their biological families.
One possible avenue for studying whether genetic and family environmental factors have differential influences on the transmission of VTE is a follow-up study of a large sample of adoptees. 29 Studies on adoptees offer the unique opportunity to study the genetic transmission of VTE because adoptees do not grow up in their biological families. 29 Transmission of VTE from biological parents to offspring would therefore be explained by genetic factors rather than family environment in adoptees. In addition, transmission of VTE from adoptive parents to their nonbiological offspring would be explained by family environment rather than genetic factors.
The Swedish Multi-Generation Register consists of data of more than nine million individuals born from 1932 onward. 30, 31 Information is available on mothers and fathers in 97% and 95%, respectively, of index persons. 30, 31 In a previous study of coronary heart disease among adoptees, it was possible to identify 80 214 Swedish-born adoptees who were linked to their biological parents and adoptive parents. 32 The study indicated that the familiar transmission of coronary heart disease from parents to offspring is more related to genetic factors than to family environmental factors.
Aims
To the best of our knowledge, no previous study of familial transmission of VTE has focused on adoptees. This study uses the Swedish Multi-Generation Register. The study had 2 aims: (1) to examine the risk of VTE in adoptees with ≥1 biological parent affected by VTE, and (2) to examine the risk of VTE in adoptees with ≥1 adoptive parent affected by VTE. The control groups consisted of adoptees without a biological parent affected by VTE (first aim) and adoptees without an adoptive parent affected by VTE (second aim).
Materials and Methods

Data Sources
The study was approved by the Ethics Committee at Lund University, and recommendations of the Declaration of Helsinki were complied with. Informed consent was waived as a requirement by the ethics committee. The data set used in this study was constructed by linking the total population register, the Multi-Generation Register, the Swedish Hospital Discharge Register, and the Swedish Cause of Death Register provided by Statistics Sweden and the National Board of Health and Welfare. 30, 31, 33 Information from the various registers in the database is linked at the individual level via the national 10-digit civic registration number assigned to each resident in Sweden for his or her lifetime. Before inclusion in the data set, civic registration numbers were replaced by serial numbers to preserve the anonymity of all individuals. Using these linked data, we were able to identify our study population-80 214 Swedish-born adoptees born between 1932 and 2004-and to link them to their biological and adoptive parents. It was possible to link 84% of the total population of adoptees to their biological and adoptive parents. The analyses were limited to Swedish-born individuals because first-generation immigrants cannot be linked to their biological parents if the latter are not registered in Sweden. Data on age at adoption were not available. However, from other sources we know that most adoptions were made from unwanted pregnancies in young unmarried women. [34] [35] [36] The children were taken into institutional care by the municipalities shortly after birth to be adopted at a median age of 6 months, and few children were adopted at a later age than 12 months. [34] [35] [36] Boys tended to be adopted at a later age than girls, and children with early signs of disability were often exempted from adoption and cared for in foster care or institutions.
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VTE Predictor and Outcome Variables
The predictor variable was first hospitalization for VTE during the study period (1964 33 The validity of VTE diagnosis has been reported to be 95%, 38 which is similar to other cardiovascular disorders such as myocardial infarction and stroke. 33 
Explanatory Variables
Sex was categorized as male and female subjects. Age at first hospital admission for VTE was categorized into 5-year groups. Educational level was classified into 3 categories: completion of compulsory schooling or less (9 years), completion of high school or some theoretical high school (10-12 years), and further education after high school (>12 years). Time period was divided into 5-year intervals. Geographic region of residence was divided into large cities (those with a population of >200 000, ie, Stockholm, Gothenburg, and Malmo), Southern Sweden, and Northern Sweden.
Statistical Analysis
Person-years were calculated for adoptees from the start of the study period (January 1, 1964) until first hospital admission for VTE, death, emigration, or the end of the study period (December 31, 2010). Agespecific standardized incidence ratios (SIRs) (for first hospitalization during the study period) were calculated for the entire study period and are presented with 95% confidence intervals, calculated assuming a Poisson distribution. 39 SIRs were calculated for each sex separately and presented by age group. Adjustments were made for education, time period, and region of residence. Overall age-specific SIRs (both men and women included) were also calculated, after adjustment for sex, education, time period, and region of residence. Familial risks for adoptees with ≥1 biological or adoptive parent affected by VTE were calculated through comparison with adoptees whose biological or adoptive parents were not affected by VTE. Familial risks were also calculated in the following 4 groups: (1) biological parents without VTE and adoptive parents without VTE, (2) biological parents with VTE and adoptive parents without VTE, (3) biological parents without VTE and adoptive parents with VTE, and (4) biological parents with VTE and adoptive parents with VTE. In these 4 groups, we estimated the risk of VTE using the first groups as the reference.
The SIRs for adoptees were calculated as the ratio of observed (O) and expected (E) number of VTE cases using the indirect standardization method:
where O O j = ∑ denotes the total observed number of cases in the study group; E * (expected number) is calculated by applying stratum-spcific standard incidence rates ( ) * λ j obtained from the reference group to the stratum-specific person-years ( ) n j of risk or the study group; O j represents the observed cases that the cohort subjects contribute to the jth stratum; and J represents the strata defined by cross-classification of the different adjustment variables. 39 Ninety-five percentage confidence intervals were calculated assuming a Poisson distribution.
Results
Of the 80 214 adoptees born from 1932 to 2004, 1574 were hospitalized for VTE during the study period (1964 through 2010) ( Table 1 ). The incidence rate of VTE was lower among adoptees with >12 years education compared with those adoptees with lower educational levels. Incidence rates for VTE were higher at older ages compared with at younger ages. The VTE rate was 64.0 per 100 000 person-years in adoptees with ≥1 biological parent with VTE compared with 53.8 per 100 000 person-years in adoptees without a biological parent with VTE. The distribution of age at VTE diagnosis, birth year, and time period for VTE diagnosis are shown in Table 1 
Familial Risks in Adoptees With Affected Biological Parents
The SIRs for VTE in adoptees with ≥1 biological parent with VTE compared with those without a biological parent with VTE are shown in 
Familial Risks in Adoptees With Affected Adoptive Parents
The SIRs for VTE in adoptees with ≥1 adoptive parent with VTE compared with those without an adoptive parent with VTE are shown in Table 3 . In contrast to the increased SIRs among adoptees with ≥1 biological parent with VTE, the overall SIRs for adoptees with ≥1 adoptive parent with VTE were not significantly different from that of the reference (SIR=1.07), after adjustment for sex, age at first hospitalization for VTE, educational level, time period, and geographic region of residence (Table 3) . Only among male adoptees, a marginally significant increased SIR of 1.25 (95% confidence interval 1.00-1.54) was observed. This increase was most likely driven by the significantly increased familial risk for VTE among male adoptees ≥50 years (SIR=1.42). The mean age at VTE diagnosis for adoptees with an affected adoptive parent was 50.6±12.0 years and 49.2±13.7 years for adoptees without an affected adoptive parent (P=0.22) (not shown in the table).
Familial Risks in Adoptees by Affected Biological and Adoptive Parents
Only 8 men and 7 women had both an affected biological parent and an affected adoptive parent (Table 4 ). In the calculations for biological familial risks, they were classified as having an affected biological parent (Table 2) , and in the analysis of nonbiological familial risks they were classified as having an affected adoptive parent (Table 3) . In Table 4 , we also present data after the exclusion of these totally 15 cases among adoptees with affected biological parents only and adoptees with affected adoptive parents only. These results are summarized in the Figure. The results are similar to those in Tables 2 and 3 . The familial risk for those with both affected biological and adoptive parents was nonsignificant compared with those adoptees without any affected biological or adoptive parent, probably because of the low number of individuals.
Familial Risks for Different Manifestations of VTE
We tested for heterogeneity of the familial risks for the different manifestations of VTE (Table 5) . No increased risk for venous thrombosis of the lower extremities (venous thrombosis), PE, or other forms of venous thrombosis was observed in adoptees with ≥1 adoptive parent with VTE; however, the numbers were low. In contrast, the risk for venous thrombosis of the lower extremities was increased in female adoptees with ≥1 biological parent with VTE, whereas the risks for PE and other forms of thrombosis were increased in male adoptees with ≥1 biological parent with VTE (Table 5) .
Discussion
This follow-up study of 80 214 Swedish adoptees linked to both their biological and adoptive parents shows that adoptees with ≥1 biological parent with VTE were 1.51 times more likely to have VTE than adoptees without a biological parent with VTE. In contrast, the overall risk in adoptees with ≥1 adoptive parent with VTE was not increased. The importance of family history in the development of VTE has been demonstrated in previous studies, which have been conducted on first-degree relatives, second-degree relatives, third-degree relatives, and twins. 12, [14] [15] [16] [17] [18] [19] [40] [41] [42] [43] [44] [45] Even PE and unusual forms of VTE have been shown to have a familial background. 18, 44 Although it is well established that genetic factors contribute to the risk of VTE, our finding that genetic factors seem to be more important for the familial transmission of VTE than family environmental factors is novel. The potential to disentangle the contributions of genetic and family environmental factors to the familial transmission of VTE stems from the fact that adoptees do not share the same family environment as their biological parents. 29 The present study provides important knowledge for planning futures studies with the aim of explaining the missing familial heritability of VTE.
In the present study, the biological familial risk was slightly but not significantly higher among men than women. However, the low numbers do not allow us to draw any firm conclusions regarding this subanalysis. A Danish twin study has previously found a significantly increased risk for VTE only among male monozygotic twins, 45 and a Swedish nationwide family study found that the familial transmission was highest among men. 40 The cause of the potentially stronger male familial transmission in those studies remains to be determined. Another issue is that the biological familial risk was increased for the different VTE manifestations, that is, venous thrombosis of the legs, PE, and other forms of VTE (Table 4 ). This is in-line with previously published nationwide family studies. 17, 18, [40] [41] [42] [43] [44] A further observation is that the biological familial risk (SIR=1.51) was slightly lower than previously published (familial risk ≈2).
12, [14] [15] [16] [17] [18] [19] [40] [41] [42] [43] [44] The explanation may, however, simply be because of the relatively lower power in a study only including adoptees. However, a possible hypothesis for the modest familial risk of 1.51 is that the higher familial transmission observed in nonadopted offspring 17, 18, [40] [41] [42] [43] [44] is because of the sum of interactions between familial genetic and environmental factors. The weak but significant association among men may suggest that such nongenetic familial factors exist (Table 3) . However, the overall familial transmission of VTE from adoptive parents to adoptees was nonsignificant (Table 3) , which argues against a large contribution of nongenetic familial factors, keeping in mind that the statistical power to detect weak effects in CI indicates confidence interval; O, observed number of cases; and SIR, standardized incidence ratio. SIRs are adjusted for sex (not sex-specific SIRs), time period, geographic region of residence, and educational attainment. SIRs for males are calculated only for males with and without family history, and SIRs for females are calculated only for females with and without family history.
* 95% CI does not include 1.00. CI indicates confidence interval; O, observed number of cases; and SIR, standardized incidence ratio. SIRs are adjusted for sex (not sex-specific SIRs), age, time period, geographic region of residence, and educational attainment. SIRs for males are calculated only for males with and without family history, and SIRs for females are calculated only for females with and without family history.
*95% CI does not include 1.00.
the present study of adoptees was low. We have previously reported an ≈10% increased risk among spouses, suggesting that shared familial environmental factors might be of importance. 40, 41 The nature of these familial environmental factors remains to be determined but exercise habits, diet, and socioeconomic factors have been reported to be associated with VTE.
46-49
Strengths and Limitations
One strength of the present study is the use of validated hospital discharge data. The Hospital Discharge Register has high validity, 33 especially for cardiovascular disorders such as VTE, stroke, and myocardial infarction (≈95%). 33, 38 Another advantage is that the use of hospital diagnoses allows for the elimination of any recall bias. Recall and self-report bias are common problems in many case-control studies and other studies of familial transmission of VTE that rely on self-report. [7] [8] [9] [10] [11] [12] [14] [15] [16] Self-reported bias is likely to be especially problematic in adoptee studies because many adoptees have no knowledge of the health status of their biological parents. The unique Swedish Total Population Register is highly complete (≈100%), with few missing data. Data in the Swedish Hospital Discharge Register are also highly complete. In 2001, the main diagnosis was missing in 0.9% and the national registration in 0.4% of hospitalizations. 30 The use of a personal identification number made it possible to track each individual in the different data registers, which meant that there were no losses to follow-up. Finally, we checked our results using the Poisson regression, but the results were close to the presented familial SIRs and are therefore not shown.
A potential limitation of this study is the lack of information on individual risk factors for VTE. However, as this most likely affected the biological and adoptive parents and the different subcategories of adoptees (adoptees with biological or adoptive parents with VTE and adoptees without biological or adoptive parents with VTE) to an equal extent, it is likely that this potential bias is nondifferential. In addition, a previous study by Bezemer et al 12 demonstrated that the familial risk of VTE is important in both the presence and the absence of acquired and established genetic risk factors. The lack of outpatient data is also likely to be a source of nondifferential bias that was partly compensated by the long study period, which increased the probability of detecting VTE cases in hospital records. Moreover, before 1987, the nationwide coverage is incomplete, which most likely is a nondifferential bias. Nonpaternity is a potential source of bias in studies of familial transmission. Adoptee studies may be affected by nonpaternity and nonmaternity that results from hidden adoptions (ie, when a child is never told he or she was adopted). Our study, however, was not significantly affected by this potential source of bias because all adoptions in Sweden are registered in a nationwide database. In addition, the large number of comparisons is a point worthy consideration. Although some researchers advocate correcting for multiple comparisons, others argue that such corrections may lead to an underestimation of effects. 50 Moreover, the statistical power in some of the subgroups of adoptees was low. This is in contrast to our previous family studies of all offspring born 1932 and later. 17, 18, [40] [41] [42] [43] [44] Some children may have been adopted by biological relatives. However, this will only cause a problem if adoptive parents transmitted VTE to their offspring, which may be a potential source of error for the marginally significant overall risk in male adoptees. Another limitation is that we had no information on the age at which children were adopted although it is likely that most adoptions occurred in early childhood. Previous reports indicate that many children were adopted before 12 months of age. [34] [35] [36] Finally, the adoptive parents were older than the biological parents at the age of VTE diagnosis (73.5 versus 61.8 years, respectively), which is explained by the age distribution where adoptive parents were older than biological parents. [34] [35] [36] As increasing age is a risk factor for VTE, this could explain why more adoptive than biological parents had had VTE. However, this is not likely to affect the SIRs in the calculations of the biological and nonbiological familial risks.
Conclusions
These novel findings suggest that genetic/biological factors make a stronger contribution to the familial transmission of VTE from parents to offspring than family environmental factors, which may shed new light on the problems with missing heritability.
CLINICAL PERSPECTIVE
Venous thromboembolism (VTE) is a major medical health problem. VTE is considered a complex disorder influenced by several genetic and environmental factors. VTE clusters in families, but the familial risk of VTE has not been determined among adoptees. This nationwide study sought to disentangle the contributions of genetic and environmental factors to the familial transmission of VTE. The Swedish Multi-Generation Register was used to follow 80 214 Swedish-born adoptees for VTE. The risk of VTE was estimated in adoptees with ≥1 biological parent with VTE compared with adoptees without a biological parent with VTE. The risk of VTE was also estimated in adoptees with ≥1 adoptive parent with VTE compared with adoptees without an adoptive parent with VTE. Adoptees with ≥1 biological parent with VTE (n=137) were more likely to have VTE than adoptees without a biological parent with VTE (standardized incidence ratio) 1.51; 95% confidence interval 1.27 to 1.79. The standardized incidence ratio for VTE was highest for adoptees with a biological parent diagnosed with VTE before the age of 50 years (standardized incidence ratio =2.03, 1.24-3.14). In contrast, adoptees with ≥1 adoptive parent with VTE (n=156) were not at increased risk of VTE (standardized incidence ratio =1.07, 0.91-1.25). These novel findings suggest that genetic factors make a stronger contribution to the familial transmission of VTE from parents to offspring than family environmental factors. In clinical practice, a familial clustering of VTE in a biological parent and offspring suggests a genetic risk factor for VTE to be sought.
